Identification of novel phosphoproteomic biomarkers in patients with advanced hepatocellular carcinoma (HCC)

被引：0
|
作者：
Sarker, Debashis
Pedicona, Federico
Zen, Yoh
Borek, Weronika E.
Khorsandi, Shirin Elizabeth
Christopher, Josie
Karampera, Christina
Dowe, Thomas
Heaton, Nigel
Cutillas, Pedro Rodriguez
Dokal, Arran David
Britton, David James
机构：
[1] Kings Coll London, London, England
[2] Kinom Ltd, Macclesfield, Cheshire, England
[3] Kings Coll Hosp London, London, England
[4] Kings Coll Hosp London, Inst Liver Studies, London, England
[5] Kings Coll Hosp London, London, England
[6] Queen Mary Univ London, Barts Canc Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15155
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Novel biomarkers in hepatocellular carcinoma
    De Stefano, Felice
    Chacon, Eduardo
    Turcios, Lilia
    Marti, Francesc
    Gedaly, Roberto
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (11) : 1115 - 1123
  • [32] A phase I study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Yopp, Adam
    Arriega, Yuii
    Singal, Amit
    Mansour, John
    Bach, Glen
    Thorpe, Phillip
    CANCER RESEARCH, 2012, 72
  • [33] Phase I/II study of everolimus in patients with advanced hepatocellular carcinoma (HCC)
    Blaszkowsky, L. S.
    Abrams, T. A.
    Miksad, R. A.
    Zheng, H.
    Meyerhardt, J. A.
    Schrag, D.
    Kwak, E. L.
    Fuchs, C.
    Ryan, D. P.
    Zhu, A. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] EGFR expression in advanced hepatocellular carcinoma (HCC): an autopsy study in cirrhotic patients
    Silva, F. A.
    Cassol, C. A.
    Goncalves, F. R.
    Wakamatsu, A.
    Cirqueira, C. S.
    Ressio, R. A.
    Alves, V. A. F.
    HISTOPATHOLOGY, 2010, 57 : 164 - 164
  • [35] dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers
    Chu, Yen-Wei
    Chien, Ching-Hsuan
    Sung, Mei-, I
    Chen, Chi-Wei
    Chen, Yu-Ting
    PLOS ONE, 2020, 15 (06):
  • [36] A novel combinatorial therapy for hepatocellular carcinoma (HCC)
    Srivastava, Jyoti
    Rajasekaran, Devaraja
    Siddiq, Ayesha
    Gredler, Rachel
    Robertson, Chadia L.
    Akiel, Maaged A.
    Shen, Xue-Ning
    Ebeid, Kareem A. N.
    Salem, Aliasger K.
    Fisher, Paul B.
    Sarkar, Devanand
    CANCER RESEARCH, 2015, 75
  • [37] Tumor biomarkers and regorafenib (REG) efficacy in patients with hepatocellular carcinoma (HCC) in the RESORCE trial
    Teufel, Michael
    Seidel, Henrik
    Kochert, Karl
    Meinhardt, Gerold
    Finn, Richard S.
    Llovet, Josep M.
    Bruix, Jordi
    HEPATOLOGY, 2017, 66 : 756A - 757A
  • [38] Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment
    Kim, Kyung
    Jha, Reena
    Prins, Petra A.
    Wang, Hongkun
    Chacha, Monica
    Hartley, Marion L.
    He, Aiwu Ruth
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (05) : 945 - 954
  • [39] Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment
    Kyung Kim
    Reena Jha
    Petra A. Prins
    Hongkun Wang
    Monica Chacha
    Marion L. Hartley
    Aiwu Ruth He
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 945 - 954
  • [40] Identification of novel microRNAs: Biomarkers for pathogenesis of hepatocellular carcinoma in mice model
    Priya, Shivani
    Kma, Lakhon
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2025, 41
12345